Ligand Pharmaceuticals Inc (LGND)
Cost of Revenue
$4.12M
TTM · Period ending: · USD
LGND Cost of Revenue
Latest reported$4.12Mperiod ending
Latest reported$4.12Mperiod ending
LGND TTM Cost of Revenue ($24.70M → $4.12M)
TTM cost of revenue
High-resolution chart · PNG
LGND cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 10,021,000 | |
| 5,864,000 | |
| 1,618,000 | |
| -748,000 | |
| 240,000 | |
| 1,257,000 | |
| 3,100,000 | |
| -4,700,000 | |
| -5,600,000 | |
| -6,400,000 | |
| -7,700,000 | |
| -8,100,000 | |
| -8,800,000 | |
| -9,300,000 | |
| -9,800,000 | |
| -9,600,000 | |
| -11,700,000 | |
| -10,600,000 | |
| -9,400,000 | |
| -8,100,000 | |
| -4,400,000 | |
| -3,200,000 | |
| -2,800,000 | |
| 4,600,000 | |
| 11,900,000 | |
| 18,100,000 | |
| 24,700,000 |